Literature DB >> 6323447

Properties of smooth muscle vinculin.

R R Evans, R M Robson, M H Stromer.   

Abstract

Vinculin, isolated from turkey gizzard smooth muscle, was purified by chromatography on CM-cellulose after isolation from a DEAE-cellulose column. Two-dimensional gel electrophoretic analysis of crude muscle fractions demonstrated that: 1) much of the approximately 130,000-dalton protein present in smooth muscle did not co-isoelectrically focus with the purified 130,000-dalton vinculin and 2) the purified vinculin consisted of three major, closely spaced isoelectric variants that were present only in small amounts in the original smooth muscle sample. Purified vinculin sedimented as a single peak with a sedimentation coefficient S0 20,w of 5.9. Circular dichroism spectra of purified vinculin indicated a considerable degree of secondary structure, with an alpha-helical content of approximately 50% as measured at 208 nm. The ultraviolet absorption spectrum of vinculin gave a measured E1%(278) of 4.64. Digestion of vinculin, much of which is located at the cytoplasmic surface of the cell membrane, with Ca2+-activated neutral protease purified from skeletal muscle yielded major fragments with molecular weights determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of 98,000, 85,000, and 26,000. The factor(s) in DEAE-cellulose-purified vinculin responsible for decreasing the low shear viscosity of actin was removed and found in a crude fraction isolated by CM-cellulose chromatography. The purified vinculin had a small, but positive effect on the MgCl2-induced polymerization of actin as measured by low shear viscometry.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323447

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Further characterization of the interaction between the cytoskeletal proteins talin and vinculin.

Authors:  Mark D Bass; Bipin Patel; Igor G Barsukov; Ian J Fillingham; Robert Mason; Beverley J Smith; Clive R Bagshaw; David R Critchley
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

2.  Relationship between the organization of actin bundles and vinculin plaques.

Authors:  M Schliwa; M Potter
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  The effects of a calcium dependent protease on the ultrastructure and contractile mechanics of skinned uterine smooth muscle.

Authors:  J R Haeberle; S A Coolican; A Evan; D R Hathaway
Journal:  J Muscle Res Cell Motil       Date:  1985-06       Impact factor: 2.698

Review 4.  Interaction of the cytoskeleton with the plasma membrane.

Authors:  V Niggli; M M Burger
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

5.  Acidic phospholipids inhibit the intramolecular association between the N- and C-terminal regions of vinculin, exposing actin-binding and protein kinase C phosphorylation sites.

Authors:  J Weekes; S T Barry; D R Critchley
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

Review 6.  Focal adhesion as a signal transduction organelle.

Authors:  S H Lo; L B Chen
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

7.  Isolation and characterization of a vinculin cDNA from chick-embryo fibroblasts.

Authors:  G J Price; P Jones; M D Davison; B Patel; I C Eperon; D R Critchley
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

8.  Metavinculin and vinculin from mammalian smooth muscle: bulk isolation and characterization.

Authors:  M Gimona; D O Fürst; J V Small
Journal:  J Muscle Res Cell Motil       Date:  1987-08       Impact factor: 2.698

9.  Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

Authors:  D J Law; J G Tidball
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  cDNA-derived sequence of chicken embryo vinculin.

Authors:  M D Coutu; S W Craig
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.